✦ LIBER ✦

Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine

✍ Scribed by M. Davies; K. Khunti

Book ID: 109044618
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 157 KB
Volume: 10
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2008.00844.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin therapy in elderly patients with

Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine

✍ H. U. Janka 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Insulin therapy in type 2 diabetes: role

Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue

✍ H. Yki-Järvinen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Cost-effectiveness of biphasic insulin a

Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China

✍ James L. Palmer; Amélie Beaudet; Jeremy White; Juliette Plun-Favreau; Jayne Smit 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 297 KB

Insulin glargine or NPH combined with me

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

✍ H. Yki-Järvinen; R. Kauppinen-Mäkelin; M. Tiikkainen; M. Vähätalo; H. Virtamo; K 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 270 KB

Increased insulin dose requirement of lo

Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes

✍ C. Schmid; P. Krayenbühl; P. Wiesli 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 55 KB

Addition of insulin glargine or NPH insu

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

✍ A. J. Varewijck; J. A. M. J. L. Janssen; M. Vähätalo; L. J. Hofland; S. W. J. La 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 277 KB